Alyeska Investment Group’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-113,301
Closed -$997K 495
2017
Q2
$997K Buy
+113,301
New +$997K 0.01% 389